Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Trudzinski, F. C.
127  Ergebnisse:
Personensuche X
?
1

Midregional proatrial naturetic peptide (MRproANP) and cope..:

Fähndrich, S. ; Herr, C. ; Teuteberg, S....
Respiratory Research.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Statins did not reduce the frequency of exacerbations in in..:

Frantzi, N. ; Nguyen, X. P. ; Herr, C....
Respiratory Research.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Associations of oxygenated hemoglobin with disease burden a..:

Trudzinski, F. C. ; Jörres, R. A. ; Alter, P....
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
4

Combined effects of lung function, blood gases and kidney f..:

Trudzinski, F.C. ; Kahnert, K. ; Vogelmeier, C.F....
Respiratory Medicine.  154 (2019)  - p. 18-26 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Chronisch thromboembolische pulmonale Hypertonie – aktuelle..:

Trudzinski, F. C. ; Maßmann, A. ; Wilkens, H.
Der Pneumologe.  16 (2019)  5 - p. 294-302 , 2019
Link: https://doi.org/10.1007/..
 
?
6

Extrakorporale Membranoxygenierung bei akutem respiratorisc..:

Trudzinski, F. C. ; Lepper, P. M.
Medizinische Klinik - Intensivmedizin und Notfallmedizin.  112 (2017)  6 - p. 552-556 , 2017
Link: https://doi.org/10.1007/..
 
?
7

Update: akute hyperkapnische respiratorische Insuffizienz:

Seiler, F. ; Trudzinski, F. C. ; Kredel, M....
Medizinische Klinik - Intensivmedizin und Notfallmedizin.  114 (2017)  3 - p. 234-239 , 2017
Link: https://doi.org/10.1007/..
 
?
8

Functional outcomes and quality of life during long-term fo..:

Barco, S ; Valerio, L ; Jankowski, M...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
9

Midregional proatrial naturetic peptide (MRproANP) and cope..:

Fähndrich, S ; Herr, C ; Teuteberg, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10809634/.  , 2024
Link: http://www.ncbi.nlm.nih...
 
?
10

Reduced decline of lung diffusing capacity in COPD patients..:

Kahnert, K ; Andreas, S ; Kellerer, C...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-022-05276-x.  , 2022
Link: https://push-zb.helmholt..
 
?
11

Deterioration and mortality risk of COPD patients not fitti..:

Mayerhofer, B ; Jörres, R.A ; Lutter, J...
info:eu-repo/semantics/altIdentifier/doi/10.1159/000513010.  , 2021
Link: https://push-zb.helmholt..
 
?
12

COPD maintenance medication is linked to left atrial size: ..:

Kellerer, C ; Kahnert, K ; Trudzinski, F.C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.rmed.2021.106461.  , 2021
Link: https://push-zb.helmholt..
 
?
13

Treatment of COPD Groups GOLD A and B with inhaled corticos..:

Lutter, J ; Jörres, R.A ; Trudzinski, F.C...
info:eu-repo/semantics/altIdentifier/doi/10.2147/COPD.S304532.  , 2021
Link: https://push-zb.helmholt..
 
?
14

Prediction of lung emphysema in COPD by spirometry and clin..:

Kellerer, C ; Jörres, R.A ; Schneider, A...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12931-021-01837-2.  , 2021
Link: https://push-zb.helmholt..
 
?
15

Impact of the COVID-19 pandemic on the behaviour and health..:

Kahnert, K ; Lutter, J ; Welte, T...
info:eu-repo/semantics/altIdentifier/doi/10.1183/23120541.00242-2021.  , 2021
Link: https://push-zb.helmholt..
 
1-15